id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-P-0001-0001,FDA,FDA-1999-P-0001,Medical Devices; Reclassification and Codification of the Absorbable Polydioxanone Surgical Suture,Rule,Final Rule,2002-12-23T05:00:00Z,2002,12,2002-12-19T05:00:00Z,2003-01-22T04:59:59Z,2017-07-18T19:22:51Z,02–31993,0,0,09000064804a58ba
FDA-1998-N-0008-0002,FDA,FDA-1998-N-0008,Bioavailability and Bioequivalence Requirements; Abbreviated Applications; Final Rule,Rule,Final Rule,2002-12-23T05:00:00Z,2002,12,,,2024-09-27T15:54:49Z,2002-31996,0,0,0900006480558df9
FDA-2002-P-0046-0001,FDA,FDA-2002-P-0046,Food Labeling: Health Claims; D-tagatose and Dental Caries; Interim Final Rule,Rule,Interim Final Rule,2002-12-12T05:00:00Z,2002,12,2002-12-02T05:00:00Z,2003-02-19T04:59:59Z,2015-12-02T22:01:14Z,,0,0,090000648048b7f1
FDA-2002-N-0034-0003,FDA,FDA-2002-N-0034,Presiding Officers at Regulatory Hearings; Confirmation of Effective Date,Rule,Confirmation of Effective Date,2002-12-11T05:00:00Z,2002,12,2002-12-02T05:00:00Z,,2025-05-06T16:45:50Z,02-30483,0,0,090000648048af46
FDA-2001-Q-0085-0001,FDA,FDA-2001-Q-0085,Food Labeling: Health Claims; Soluble Dietary Fiber From Certain Foods and Coronary Heart Disease; Interim Final Rule,Rule,Interim Final Rule,2002-10-04T04:00:00Z,2002,10,2002-10-02T04:00:00Z,2002-12-17T04:59:59Z,2016-01-06T19:39:04Z,,0,0,09000064804b8486
FDA-2002-N-0034-0002,FDA,FDA-2002-N-0034,Presiding Officers at Regulatory Hearings,Rule,Direct Final Rule,2002-08-20T04:00:00Z,2002,8,2002-08-15T04:00:00Z,2002-10-30T04:59:59Z,2025-05-06T16:43:12Z,02-20701,0,0,090000648048af3b
FDA-2000-C-0236-0004,FDA,FDA-2000-C-0236,Listing of Color Additives Exempt From Certification; Sodium Copper Chlorophyllin; Confirmation of Effective Date,Rule,Confirmation of Effective Date,2002-08-05T04:00:00Z,2002,8,,,2017-08-30T19:59:47Z,02-19300,0,0,09000064804d58e5
FDA-2000-N-0041-0001,FDA,FDA-2000-N-0041,Final rule re Postmarket Surveillance,Rule,Final Rule,2002-06-10T04:00:00Z,2002,6,,,2015-11-14T02:31:29Z,,0,0,09000064804aef19
FDA-1998-N-1290-0001,FDA,FDA-1998-N-1290,New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible,Rule,NFR-Notice of Final Rule,2002-06-04T04:00:00Z,2002,6,,,2009-04-23T22:59:35Z,,0,0,09000064805a6f2d
FDA-2000-C-0236-0003,FDA,FDA-2000-C-0236,Listing of Color Additives Exempt From Certification; Sodium Copper Chlorophyllin,Rule,Final Rule,2002-05-20T04:00:00Z,2002,5,,,2017-08-30T19:38:37Z,02-12544,0,0,09000064804d58e3
FDA-1978-N-0021-0008,FDA,FDA-1978-N-0021,Final Rule; Status of Certain Additional Over-the-Counter Drug Category II and Ill Active Ingredients,Rule,Final Rule,2002-05-10T04:00:00Z,2002,5,,,2016-08-03T20:09:29Z,,0,0,090000648055d5e4
FDA-2001-N-0229-0001,FDA,FDA-2001-N-0229,Topical Nitrofurans; Extralabel Animal Drug Use; Order of Prohibition,Rule,Final Rule,2002-02-08T05:00:00Z,2002,2,2002-02-06T05:00:00Z,2002-04-09T03:59:59Z,2025-02-06T13:56:48Z,02-2751,0,0,09000064804e5af1
FDA-1999-N-0097-0001,FDA,FDA-1999-N-0097,Final Rule re State Certification Mammography Facilities,Rule,Final Rule,2002-02-08T05:00:00Z,2002,2,2002-02-08T05:00:00Z,2002-02-07T04:59:59Z,2024-10-04T15:30:05Z,65FR16847,0,0,09000064804a6aff
FDA-1996-N-0006-0004,FDA,FDA-1996-N-0006,Notice of Final Rule re Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded,Rule,Final Rule,2002-01-25T05:00:00Z,2002,1,,,2015-05-05T15:08:46Z,,0,0,09000064804f9964